Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Aravindhan Veerapandiyan

Concepts (208)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Muscular Atrophy, Spinal
5
2024
13
3.160
Why?
Muscular Dystrophy, Duchenne
4
2024
18
2.670
Why?
Oligonucleotides
4
2020
81
2.150
Why?
Pneumonia, Viral
3
2020
169
1.710
Why?
Coronavirus Infections
3
2020
178
1.680
Why?
Spastic Paraplegia, Hereditary
2
2022
2
1.650
Why?
Mutation
12
2023
1294
1.560
Why?
Genetic Therapy
4
2024
114
1.500
Why?
Disease Management
2
2020
176
1.280
Why?
Dystonic Disorders
2
2023
6
1.250
Why?
Pandemics
4
2022
562
1.170
Why?
Spasms, Infantile
2
2018
27
1.000
Why?
Epilepsy
2
2022
177
0.980
Why?
Humans
45
2024
50208
0.970
Why?
Neuromuscular Diseases
1
2024
30
0.920
Why?
Child
20
2023
6851
0.910
Why?
Spinal Muscular Atrophies of Childhood
2
2020
9
0.910
Why?
Peroneal Neuropathies
2
2021
5
0.900
Why?
Recombinant Fusion Proteins
2
2024
186
0.900
Why?
Intellectual Disability
2
2022
124
0.890
Why?
Dystonia
1
2023
10
0.880
Why?
Nerve Tissue Proteins
2
2021
193
0.820
Why?
Myasthenic Syndromes, Congenital
1
2021
7
0.790
Why?
Chromosomes, Human, Pair 22
2
2011
39
0.750
Why?
Fasciculation
1
2020
2
0.740
Why?
Isaacs Syndrome
1
2020
2
0.740
Why?
Hereditary Sensory and Motor Neuropathy
1
2020
3
0.740
Why?
Seizures
3
2018
196
0.730
Why?
Muscular Dystrophies
1
2020
15
0.720
Why?
Myopathies, Structural, Congenital
1
2020
10
0.720
Why?
Codon, Nonsense
1
2020
26
0.720
Why?
Anticonvulsants
2
2012
122
0.720
Why?
Apoptosis Regulatory Proteins
1
2020
86
0.700
Why?
Charcot-Marie-Tooth Disease
1
2019
9
0.690
Why?
Phenotype
3
2020
733
0.690
Why?
Glucocorticoids
3
2020
226
0.690
Why?
Epstein-Barr Virus Infections
1
2020
30
0.690
Why?
Male
25
2021
25399
0.680
Why?
Encephalitis
2
2017
41
0.660
Why?
Consensus
1
2020
150
0.660
Why?
Adaptor Proteins, Signal Transducing
1
2020
198
0.660
Why?
Adolescent
14
2021
6390
0.660
Why?
Multiple Sclerosis
1
2019
66
0.660
Why?
Infant
9
2020
3563
0.660
Why?
Chromosome Duplication
1
2018
7
0.640
Why?
Survival of Motor Neuron 1 Protein
1
2018
3
0.640
Why?
Munc18 Proteins
1
2018
3
0.630
Why?
Spinal Puncture
1
2018
16
0.630
Why?
Microfilament Proteins
1
2018
43
0.620
Why?
Electroencephalography
6
2018
307
0.620
Why?
Epilepsies, Myoclonic
1
2018
11
0.620
Why?
Head
1
2018
73
0.610
Why?
Chromosomes, Human, Pair 1
1
2018
93
0.610
Why?
Chromosome Deletion
3
2018
140
0.580
Why?
Central Nervous System Diseases
1
2017
27
0.580
Why?
Delivery of Health Care
1
2020
310
0.580
Why?
Pedigree
3
2022
125
0.570
Why?
Dystrophin
2
2020
5
0.560
Why?
Attention Deficit Disorder with Hyperactivity
1
2018
172
0.550
Why?
Carrier Proteins
1
2018
306
0.550
Why?
Child, Preschool
10
2024
3883
0.530
Why?
Muscular Diseases
2
2020
61
0.530
Why?
DiGeorge Syndrome
2
2012
17
0.480
Why?
Emergency Service, Hospital
1
2018
484
0.470
Why?
Female
18
2021
26635
0.460
Why?
Tomography, X-Ray Computed
1
2018
1161
0.430
Why?
Brain
2
2018
1328
0.410
Why?
Epilepsy, Complex Partial
1
2012
3
0.410
Why?
Carbamazepine
1
2012
13
0.410
Why?
Epilepsy, Tonic-Clonic
1
2011
3
0.380
Why?
Cephalometry
1
2011
17
0.380
Why?
Pyridoxal Phosphate
1
2011
10
0.380
Why?
Myoglobinuria
1
2010
2
0.380
Why?
Triazines
1
2011
24
0.380
Why?
Epilepsy, Absence
1
2011
11
0.370
Why?
Ocular Motility Disorders
1
2011
17
0.370
Why?
BRCA2 Protein
1
2010
15
0.370
Why?
Pseudolymphoma
1
2010
4
0.370
Why?
Velopharyngeal Insufficiency
1
2011
19
0.370
Why?
Retrospective Studies
7
2021
6134
0.360
Why?
Prednisolone
3
2020
55
0.360
Why?
Mutation, Missense
1
2010
105
0.350
Why?
Drug Overdose
1
2011
163
0.320
Why?
Treatment Outcome
4
2020
5155
0.310
Why?
Diagnosis, Differential
3
2020
1043
0.300
Why?
Drug Therapy, Combination
2
2020
381
0.250
Why?
Follow-Up Studies
3
2021
2190
0.250
Why?
Muscle, Skeletal
1
2010
765
0.250
Why?
Young Adult
6
2021
3981
0.250
Why?
Heterozygote
2
2023
81
0.250
Why?
Histone-Lysine N-Methyltransferase
1
2023
55
0.210
Why?
Magnetic Resonance Imaging
3
2018
1541
0.200
Why?
Adenosine Triphosphatases
1
2022
87
0.200
Why?
Semaphorins
1
2021
3
0.200
Why?
Atrophy
1
2022
38
0.200
Why?
Patient Care Planning
1
2022
67
0.200
Why?
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
2021
4
0.190
Why?
Cell Adhesion Molecules
1
2021
89
0.190
Why?
Cohort Studies
2
2018
1422
0.190
Why?
Receptors, Cell Surface
1
2021
125
0.190
Why?
Introns
2
2018
48
0.180
Why?
Adult
7
2022
13324
0.180
Why?
Muscle Cramp
1
2020
5
0.180
Why?
Health Services Accessibility
1
2024
399
0.180
Why?
Recovery of Function
1
2021
187
0.180
Why?
Flavoproteins
1
2019
5
0.180
Why?
Injections, Spinal
1
2019
19
0.180
Why?
Palliative Care
1
2022
186
0.170
Why?
Phosphoric Monoester Hydrolases
1
2019
21
0.170
Why?
Physical Endurance
1
2019
30
0.170
Why?
Hand Strength
1
2019
23
0.170
Why?
Facial Paralysis
1
2020
24
0.170
Why?
Muscle Weakness
1
2020
44
0.170
Why?
Neurologic Examination
1
2019
77
0.170
Why?
Age of Onset
1
2019
107
0.170
Why?
Steroids
1
2019
57
0.170
Why?
Membrane Proteins
1
2022
353
0.170
Why?
Abnormalities, Multiple
2
2011
167
0.170
Why?
Age Factors
3
2018
1092
0.170
Why?
Scoliosis
1
2019
60
0.160
Why?
Aminomethyltransferase
1
2018
1
0.160
Why?
Hyperglycinemia, Nonketotic
1
2018
5
0.160
Why?
Spinal Fusion
1
2019
70
0.160
Why?
Hyperammonemia
1
2018
18
0.160
Why?
Activities of Daily Living
1
2019
173
0.160
Why?
Lumbosacral Region
1
2018
12
0.160
Why?
X-Rays
1
2018
55
0.160
Why?
Neuraminidase
1
2018
3
0.160
Why?
Anti-Inflammatory Agents
1
2019
160
0.160
Why?
Mucolipidoses
1
2018
4
0.160
Why?
Pons
1
2017
33
0.150
Why?
Methylprednisolone
1
2017
38
0.150
Why?
Prevalence
1
2020
951
0.140
Why?
Brain Stem
1
2017
57
0.140
Why?
Disease Progression
1
2019
831
0.140
Why?
Cross-Sectional Studies
2
2019
1554
0.140
Why?
Quality of Life
1
2022
839
0.130
Why?
Aged
3
2021
9405
0.120
Why?
T-Lymphocytes
1
2017
339
0.120
Why?
RNA, Messenger
1
2018
1108
0.120
Why?
Chronic Disease
1
2017
571
0.120
Why?
Antibodies
2
2012
154
0.120
Why?
Kv1.1 Potassium Channel
1
2013
2
0.110
Why?
Middle Aged
3
2021
12206
0.110
Why?
Dipeptides
1
2012
22
0.100
Why?
Aspartic Acid
1
2012
49
0.100
Why?
Folic Acid Deficiency
1
2012
43
0.100
Why?
Folate Receptor 1
1
2012
24
0.100
Why?
Ear
1
2011
17
0.100
Why?
Prefrontal Cortex
1
2012
83
0.100
Why?
Hypoparathyroidism
1
2011
5
0.100
Why?
Immune System Diseases
1
2011
8
0.100
Why?
Facies
1
2011
35
0.100
Why?
Eye Abnormalities
1
2011
25
0.100
Why?
Nose
1
2011
31
0.100
Why?
Epilepsies, Partial
1
2011
12
0.100
Why?
Platybasia
1
2011
5
0.100
Why?
Frontal Lobe
1
2011
48
0.090
Why?
Infant, Newborn
1
2018
2766
0.090
Why?
Receptors, N-Methyl-D-Aspartate
1
2011
127
0.090
Why?
Glycogen Storage Disease Type III
1
2010
1
0.090
Why?
Glycogen Debranching Enzyme System
1
2010
2
0.090
Why?
Cervical Vertebrae
1
2011
58
0.090
Why?
Genetic Heterogeneity
1
2010
18
0.090
Why?
Genetic Predisposition to Disease
1
2013
509
0.090
Why?
Syndrome
1
2010
238
0.090
Why?
Cleft Palate
1
2011
78
0.090
Why?
Brain Mapping
1
2011
235
0.090
Why?
Cognition Disorders
1
2011
215
0.090
Why?
United States
1
2020
4874
0.080
Why?
Lymph Nodes
1
2010
263
0.080
Why?
Myocardium
1
2010
438
0.070
Why?
Skin
1
2010
415
0.070
Why?
Dose-Response Relationship, Drug
1
2011
1378
0.070
Why?
Exercise
1
2010
503
0.070
Why?
Heart Defects, Congenital
1
2011
585
0.060
Why?
Delphi Technique
1
2024
49
0.060
Why?
Myocarditis
1
2024
43
0.050
Why?
Azo Compounds
1
2022
10
0.050
Why?
Electrodiagnosis
1
2021
12
0.050
Why?
Genetic Association Studies
1
2021
116
0.050
Why?
Pyrimidines
1
2022
193
0.050
Why?
Homozygote
1
2018
57
0.040
Why?
Signal Transduction
1
2021
1622
0.030
Why?
Flurothyl
1
2013
1
0.030
Why?
Kindling, Neurologic
1
2013
3
0.030
Why?
Mice, Mutant Strains
1
2013
71
0.030
Why?
Aged, 80 and over
1
2021
3154
0.030
Why?
Animals, Newborn
1
2013
368
0.030
Why?
Protons
1
2012
69
0.020
Why?
Chi-Square Distribution
1
2012
278
0.020
Why?
Hippocampus
1
2013
228
0.020
Why?
Magnetic Resonance Spectroscopy
1
2012
245
0.020
Why?
Autoantibodies
1
2011
116
0.020
Why?
Anisotropy
1
2011
63
0.020
Why?
Drug Resistance
1
2011
64
0.020
Why?
Video Recording
1
2011
80
0.020
Why?
Neuropsychological Tests
1
2012
355
0.020
Why?
Diffusion Magnetic Resonance Imaging
1
2011
124
0.020
Why?
Sequence Homology, Amino Acid
1
2010
144
0.020
Why?
Exons
1
2010
95
0.020
Why?
Amino Acid Sequence
1
2010
586
0.020
Why?
Molecular Sequence Data
1
2010
793
0.020
Why?
Disease Models, Animal
1
2013
1458
0.020
Why?
Mice, Inbred C57BL
1
2013
1819
0.020
Why?
Case-Control Studies
1
2011
1126
0.020
Why?
Mice
1
2013
5759
0.010
Why?
Animals
1
2013
13246
0.010
Why?
Veerapandiyan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description